Skip to main content

Animations

MJFF Publications

4051 - 4060 of 8823 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2021
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2013
  • 2023
  • Summary Details
    OPEN
    Title: Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-15874-4
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-022-03002-x
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00247-x
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Gut mucosal cells transfer α-synuclein to the vagus nerve
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.172192
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Regulation of expression quantitative trait loci by SVA retrotransposons within the major histocompatibility complex
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15353702231209411
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.113544
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
    Journal Name: IBRO Neuroscience Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.11.001
    Citation Count: 252
  • Summary Details
    OPEN
    Title: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.050605
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.